Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

Published:2019-03 Issue: Volume:109 Page:154-161
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Segal Neil H.,Ou Sai-Hong I.,Balmanoukian Ani,Fury Matthew G.,Massarelli Erminia,Brahmer Julie R.,Weiss Jared,Schöffski Patrick,Antonia Scott J.,Massard Christophe,Zandberg Dan P.,Khleif Samir N.,Xiao Feng,Rebelatto Marlon C.,Steele Keith E.,Robbins Paul B.,Angra Natasha,Song Xuyang,Abdullah Shaad,Butler Marcus

Funder

Roche

Genentech

Pfizer

Merck

Bristol-Myers Squibb

MedImmune

AstraZeneca

Incyte

Takeda

Ariad

Blueprint Medicines

TP Therapeutics

Tessa

GlaxoSmithKline

Celgene

Boehringer-Ingelheim

Cobiores NV

Eisai

Eli Lilly

Exelixis

G1 Therapeutics

Novartis

PharmaMar

Plexxikon

Neurogenics

Syndax

IO Biotech

Bioline

Lycera

Takara

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Immune checkpoint inhibition in head and neck cancer;Forster;Front Oncol,2018

2. Therapeutic strategy for cancer immunotherapy in head and neck cancer;Ishii;Adv Cellular Mol Otolaryngol,2015

3. Immunotherapy in head and neck cancer: aiming at EXTREME precision;Szturz;BMC Med,2017

4. The mutational landscape of head and neck squamous cell carcinoma;Stransky;Science,2011

5. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment;Pai;Annu Rev Pathol,2009

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of contemporary phase I trials in patients with recurrent/metastatic head and neck cancer;Oral Oncology Reports;2024-09

2. Analysis of clinical efficacy and long-term prognosis of patients with hepatocellular carcinoma treated with PD-L1 inhibitor targeting;Technology and Health Care;2024-05-16

3. Immunotherapy in elderly head and neck cancer patients: a systematic review and meta-analysis;Frontiers in Oncology;2024-05-10

4. Research progress of immunotherapy for advanced head and neck cancer;Medical Oncology;2024-05-04

5. Rethinking treatment paradigms: Neoadjuvant therapy and de-escalation strategies in HPV-positive head and neck cancer;Critical Reviews in Oncology/Hematology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3